138 related articles for article (PubMed ID: 17222361)
1. [Screening for mutations in the hotspot mutation regions of PIK3CA gene in nasopharyngeal carcinoma].
Liu P; Li DJ; Qin HD; Zhang RH; Chen LZ; Zeng YX
Ai Zheng; 2007 Jan; 26(1):15-20. PubMed ID: 17222361
[TBL] [Abstract][Full Text] [Related]
2. PIK3CA gene mutations in breast carcinoma in Malaysian patients.
Ching-Shian Leong V; Jabal MF; Leong PP; Abdullah MA; Gul YA; Seow HF
Cancer Genet Cytogenet; 2008 Dec; 187(2):74-9. PubMed ID: 19027487
[TBL] [Abstract][Full Text] [Related]
3. PIK3CA mutations in head and neck squamous cell carcinoma.
Qiu W; Schönleben F; Li X; Ho DJ; Close LG; Manolidis S; Bennett BP; Su GH
Clin Cancer Res; 2006 Mar; 12(5):1441-6. PubMed ID: 16533766
[TBL] [Abstract][Full Text] [Related]
4. PIK3CA Mutations in Resected Small Cell Lung Cancer.
Han N; Cheng QY; Chen B; Cai JF; Wang XJ; Lou CJ; Qin J; Ye WW; Lei L; Lu HY
Adv Clin Exp Med; 2016; 25(3):397-402. PubMed ID: 27629725
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations of the PIK3CA oncogene in human oral squamous cell carcinoma in an Indian population.
Shah S; Shah S; Padh H; Kalia K
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Nov; 120(5):628-35. PubMed ID: 26453385
[TBL] [Abstract][Full Text] [Related]
6. Detection of PIK3CA mutations, including a novel mutation of V344G in exon 4, in metastatic lung adenocarcinomas: A retrospective study of 115 FNA cases.
Allison DB; Lilo MT; Geddes S; Pallavajjalla A; Askin F; Gabrielson E; Zheng G; Li QK
Cancer Cytopathol; 2016 Jul; 124(7):485-92. PubMed ID: 27007084
[TBL] [Abstract][Full Text] [Related]
7. Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients.
Tanaka Y; Kanai F; Tada M; Asaoka Y; Guleng B; Jazag A; Ohta M; Ikenoue T; Tateishi K; Obi S; Kawabe T; Yokosuka O; Omata M
Oncogene; 2006 May; 25(20):2950-2. PubMed ID: 16331247
[TBL] [Abstract][Full Text] [Related]
8. Increased Expression of Phosphatidylinositol 3-Kinase p110α and Gene Amplification of PIK3CA in Nasopharyngeal Carcinoma.
Yip WK; He PY; Abdullah MA; Yusoff S; Seow HF
Pathol Oncol Res; 2016 Apr; 22(2):413-9. PubMed ID: 26581613
[TBL] [Abstract][Full Text] [Related]
9. Absence of hotspot mutations in exons 9 and 20 of the PIK3CA gene in human oral squamous cell carcinoma in the Greek population.
Kostakis GC; Papadogeorgakis N; Koumaki V; Kamakari S; Koumaki D; Alexandridis C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):e53-8. PubMed ID: 20416519
[TBL] [Abstract][Full Text] [Related]
10. PIK3CA amplification is predictive of poor prognosis in Tunisian patients with nasopharyngeal carcinoma.
Fendri A; Khabir A; Mnejja W; Sellami-Boudawara T; Daoud J; Frikha M; Ghorbel A; Gargouri A; Mokdad-Gargouri R
Cancer Sci; 2009 Nov; 100(11):2034-9. PubMed ID: 19735264
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
[TBL] [Abstract][Full Text] [Related]
12. [Expression and mutations of PIK3CA gene in hepatocellular carcinomas].
Yang DH; Fu ZY; Huang Y; Zeng QY; Zhou J
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2517-22. PubMed ID: 20034918
[TBL] [Abstract][Full Text] [Related]
13. [A hot-spot mutation of p53 gene in nasopharyngeal carcinoma].
Chen R; Zhu D; Yin W
Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):401-4. PubMed ID: 8697986
[TBL] [Abstract][Full Text] [Related]
14. PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma.
Kozaki K; Imoto I; Pimkhaokham A; Hasegawa S; Tsuda H; Omura K; Inazawa J
Cancer Sci; 2006 Dec; 97(12):1351-8. PubMed ID: 17052259
[TBL] [Abstract][Full Text] [Related]
15. Novel method for PIK3CA mutation analysis: locked nucleic acid--PCR sequencing.
Ang D; O'Gara R; Schilling A; Beadling C; Warrick A; Troxell ML; Corless CL
J Mol Diagn; 2013 May; 15(3):312-8. PubMed ID: 23541593
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive genomic profiling of different subtypes of nasopharyngeal carcinoma reveals similarities and differences to guide targeted therapy.
Ali SM; Yao M; Yao J; Wang J; Cheng Y; Schrock AB; Chirn GW; Chen H; Mu S; Gay L; Elvin JA; Suh J; Miller VA; Stephens PJ; Ross JS; Wang K
Cancer; 2017 Sep; 123(18):3628-3637. PubMed ID: 28581676
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA mutations in intraductal papillary mucinous neoplasm/carcinoma of the pancreas.
Schönleben F; Qiu W; Ciau NT; Ho DJ; Li X; Allendorf JD; Remotti HE; Su GH
Clin Cancer Res; 2006 Jun; 12(12):3851-5. PubMed ID: 16778113
[TBL] [Abstract][Full Text] [Related]
18. PIK3CA mutation status in Japanese esophageal squamous cell carcinoma.
Mori R; Ishiguro H; Kimura M; Mitsui A; Sasaki H; Tomoda K; Mori Y; Ogawa R; Katada T; Kawano O; Harada K; Fujii Y; Kuwabara Y
J Surg Res; 2008 Apr; 145(2):320-6. PubMed ID: 18262558
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA somatic mutations are frequent in nasopharyngeal carcinoma.
Pang LJ; Shao JY; Liang XM; Xia YF; Zeng YX
Cancer Biol Ther; 2008 Feb; 7(2):198-207. PubMed ID: 18376149
[TBL] [Abstract][Full Text] [Related]
20. Activation of the PI3K/AKT signalling pathway in non-melanoma skin cancer is not mediated by oncogenic PIK3CA and AKT1 hotspot mutations.
Hafner C; Landthaler M; Vogt T
Exp Dermatol; 2010 Aug; 19(8):e222-7. PubMed ID: 20557351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
